The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in…
The National Institute for Health and Care Excellence (NICE) has rejected NHS funding for an intravenous formulation of GlaxoSmithKline's Benlysta…
Production of another potential vaccine against COVID-19 will begin within weeks, its developers Sanofi and GlaxoSmithKline said Thursday as they…
Canadian drug developer Medicago’s plant-based Covid-19 vaccine candidate, enhanced by a GlaxoSmithKline treatment, was able to create a strong antibody…